Salem News Channel

RSS Feed

Deputy AG Todd Blanche Defends Partial Release of the Epstein Files

Deputy AG Todd Blanche defends partial release of the Epstein Files, stating that eventually the DOJ will meet the obligaion to release all of the files.

Read More...

VP J.D. Vance Reflects on First Year of the Trump Admin, Major Progress Made

As the 1-year mark dawns for the 2nd Donald Trump administration, Vice President J.D. Vance says he's proud of what they have accomplished over a short amount of time.

Read More...

Harvest with Greg Laurie, December 28, 2025

Harvest with Greg Laurie, December 28, 2025

Read More...

Real Life with Jack Hibbs, December 28, 2025

Real Life with Jack Hibbs, December 28, 2025

Read More...

On the ground at Turning Point USA

On the Ground at Turning Point USA

Read More...

Trump seizes second Venezuelan oil tanker

Trump Seizes Second Venezuelan Oil Tanker

Read More...

Fulton County's 2020 Election Fraud

Fulton County's 2020 Election Fraud

Read More...

Interview With U.S. Senator Dave McCormick

Interview With U.S. Senator Dave McCormick

Read More...

The Real Explanation Significance Of The Epstein Files

The Real Explanation Significance Of The Epstein Files

Read More...

The Fraud of Fulton County; Second Oil Tanker Seized

The Fraud of Fulton County; Second Oil Tanker Seized

Read More...

More Gun Control in Australia...

Australia Prime Minister says: Firearms will be collected and destroyed.

Read More...

Brown University Shooter Found Dead

Brown University Shooter Found Dead

Read More...

Is Tucker Carlson a lunatic?

Is Tucker Carlson a Lunatic? 

Read More...

Strange Development of Brown University Shooting

Strange Development of Brown University Shooting

Read More...

Trump Admin's Interior Success in 2025

Trump Admin's Interior Success in 2025

Read More...

Justice Department releases more Epstein records

The U.S. Justice Department released a new trove of documents from its investigations into the late financier and convicted sex offender Jeffrey Epstein on Friday, bowing to pressure from lawmakers who forced their disclosure with a new law. The release follows months of political wrangling and rebellion by some of President Donald Trump's staunchest supporters over his administration's reluctance to make public all records tied to probes into Epstein. Reuters is in the process of reviewing the latest documents. Trump had initially urged fellow Republicans in Congress to oppose the new law, warning that releasing potentially sensitive internal investigative records could set a dangerous precedent. But many Trump voters accused his administration of covering up Epstein’s ties to powerful figures and obscuring details surrounding his death, which was ruled a suicide, in a Manhattan jail in 2019. Trump, who promised on the 2024 election campaign trail to declassify the government's Epstein files if elected, has been seeking to move beyond the affair so that he can concentrate on a more pressing concern for Americans - the cost of living - ahead of the November 2026 midterm elections. Just 44% of American adults who identify as Republicans approve of Trump's handling of the Epstein issue, compared to his 82% overall approval rating among the group, according to a recent Reuters/Ipsos poll. Epstein's ties to Trump have been in the spotlight since Democrats in the House of Representatives last month released thousands of emails including one in which Epstein wrote that Trump "knew about the girls" without clarifying what that meant. House Republicans released more emails the same day, including one saying Trump visited Epstein's house many times but "never got a massage." Two days after those disclosures, Trump ordered the Justice Department to investigate Epstein's connections to former Democratic President Bill Clinton and JPMorgan bank (JPM.N). The following week, despite White House pressure to delay the vote, U.S. lawmakers voted overwhelmingly to pass a bill forcing the release of the Justice Department records, which Trump then signed into law. Trump has repeatedly denied knowing about Epstein's sex trafficking but has acknowledged that the two were friends until they had a falling out before Epstein's conviction in 2008. The latest files released may not represent all unclassified records held by the agency, however, because the law ordering their release allowed the Justice Department to withhold personal information about Epstein's victims as well as material that would jeopardize an active investigation. Previous disclosures of Epstein records have revealed that even after his 2008 conviction he continued corresponding with high-profile figures, including former Trump adviser Steve Bannon, Clinton's former U.S. Treasury Secretary Larry Summers, PayPal founder Peter Thiel, and Britain's former Prince Andrew, now known as Andrew Mountbatten-Windsor, who was stripped of his royal title over revelations about his links to Epstein. Spokespeople and lawyers for Bannon, Thiel and Mountbatten-Windsor have not responded to Reuters requests for comment about their interactions with Epstein. Summers stepped back from positions at Harvard University, OpenAI and other institutions and said he was deeply ashamed of his actions after documents released by House Democrats in November showed that Summers corresponded with Epstein up through 2019, even seeking relationship advice from him. JPMorgan paid some of Epstein's victims $290 million in 2023 to settle claims that it had overlooked his sex trafficking. The bank kept Epstein on as a client for five years after he was convicted of soliciting a minor in 2008.

Read More...

Trump Strikes Deals With Pharmaceutical Companies To Cut Prices

President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government's Medicaid program and for cash payers, in his latest bid to align U.S. costs with those in other wealthy nations. Bristol Myers Squibb, Gilead Sciences, and Merck and Roche's U.S. unit Genentech have struck deals. Novartis, Amgen, Boehringer Ingelheim, Sanofi and GSK have also signed on. "We were subsidizing the entire world. We're not doing it anymore," Trump said at a White House press conference, flanked by nine drugmaker executives. Mehmet Oz, the director of the Centers for Medicare and Medicaid Service, said Regeneron, Johnson & Johnson, and AbbVie would visit the White House after the holidays for the launch of the government's TrumpRx website. Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior administration officials said, promising "massive savings" on widely used medicines without giving specific figures. U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere. The details of each deal were not immediately available but officials said they included agreements to cut cash-pay direct-to-consumer prices of select drugs sold potentially through the TrumpRx.gov website, to launch drugs in the U.S. at prices equal to - not lower than - those in other wealthy nations and to increase manufacturing. In return, companies can receive a three-year exemption from any tariffs. MERCK'S JANUVIA, JANUMET ON TRUMPRX Merck said it will sell its diabetes drugs Januvia, Janumet and Janumet XR - set to face generic competition next year - directly to U.S. consumers at about 70% off list prices. If approved, its experimental cholesterol drug enlicitide will also be offered through direct-to-consumer channels. Enlicitide is one of two Merck drugs expected to receive a speedy review under the FDA's new, fast-track pathway, Reuters previously reported. Amgen said it will expand its direct-to-patient program to include migraine drug Aimovig and rheumatoid arthritis medicine Amjevita, offering both at $299 a month - nearly 60% and 80% below current U.S. list prices In July, Trump sent letters to leaders of 17 major drugmakers, urging them to offer so-called most-favored-nation prices to Medicaid and ensure new medicines launch at prices no higher than those in other wealthy countries. Five companies had previously struck deals with the administration to rein in prices - Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk and EMD Serono, the U.S. division of Germany's Merck KGaA. The remaining three that have not announced deals are Regeneron, Johnson & Johnson, and AbbVie. Investors initially feared sweeping U.S. price controls, but the details of recent deals have largely eased those concerns. Reuters previously reported that AbbVie was expected to announce a deal on Friday. Drugmakers on Friday committed to “most-favored-nation” pricing on all new U.S. drug launches across commercial, government and cash-pay markets, including the U.S. Medicare program for those aged 65 and over, officials said. A portion of revenues from each company's foreign sales will also be remitted to the U.S. to offset costs, officials said. The companies pledged together to invest more than $150 billion in U.S. for R&D and manufacturing, according to officials, although it was unclear whether that included earlier commitments. Several also agreed to donate drug ingredients to the U.S. strategic reserve. Merck said it chipped in $70 billion of that sum. Analysts have noted that Medicaid, which accounts for only around 10% of U.S. drug spending, already benefits from substantial price discounts, exceeding 80% in some cases. Pfizer, which announced its 2026 financial outlook on Tuesday, said the Medicaid discounts would result in price and margin compression next year.

Read More...

First ... 62 63 64 65 66 ... Last

Salem News Channel Today

Sponsored Links


September 26 - Phoenix, AZ
Scottsdale Center for the Performing Arts


November 2 - Detroit, MI
Zion Christian Church in Troy


October 6 - Los Angeles, CA
Pasadena Convention Center


November 5 - San Antonio, TX
Norris Centers – The Grand Red Oak Ballroom


October 8 - Sacramento, CA
William Jessup University


November 7 - Tampa, FL
The Palladium at St. Pete College


October 22 - Minneapolis, MN
Crowne Plaza AiRE


November 15 - San Francisco, CA
Fremont Marriott Silicon Valley


October 23 - Philadelphia, PA
Green Valley Country Club


November 16 - Denver, CO
CU South Denver - Formerly Wildlife Experience


November 2 - Chicago, IL
Chicago Westin Northwest in Itasca


November 21 - Cleveland, OH
Holiday Inn Rockside in Independence



Salem Radio Network Speakers

Larry Elder is an American lawyer, writer, and radio and television personality who calls himself the "Sage of South Central" a district of Los Angeles, Larry says his philosophy is to entertain, inform, provoke and to hopefully uplift. His calling card is "we have a country to save" and to him this means returning to the bedrock Constitutional principles of limited government and maximum personal responsibility. Elder's iconoclastic wit and intellectual agility makes him a particularly attractive voice in a nation that seems weary of traditional racial dialogue.” – Los Angeles Times.

Mike Gallagher Mike Gallagher began his broadcasting career in 1978 in Dayton, Ohio. Today, he is one of the most listened-to talk radio show hosts in America, recently having been ranked in the Talkers Magazine “Heavy Hundred” list – the 100 most important talk radio hosts in America. Prior to being launched into national syndication in 1998, Mike hosted the morning show on WABC-AM in New York City. Today, Talkers Magazine reports that his show is heard by over 3.75 million weekly listeners. Besides his radio work, Mike is seen on Fox News Channel as an on-air contributor, frequently appearing on the cable news giant.

Hugh Hewitt is one of the nation’s leading bloggers and a genuine media revolutionary. He brings that expertise, his wit and what The New Yorker magazine calls his “amiable but relentless manner” to his nationally syndicated show each day.

When Dr. Sebastian Gorka was growing up, he listened to talk radio under his pillow with a transistor radio, dreaming that one day he would be behind the microphone. Beginning New Year’s Day 2019, he got his wish. Gorka now hosts America First every weekday afternoon 3 to 6pm ET. Gorka’s unique story works well on the radio. He is national security analyst for the Fox News Channel and author of two books: "Why We Fight" and "Defeating Jihad." His latest book releasing this fall is “War For America’s Soul.” He is uniquely qualified to fight the culture war and stand up for what is great about America, his adopted home country.

Broadcasting from his home station of KRLA in Los Angeles, the Dennis Prager Show is heard across the country. Everything in life – from politics to religion to relationships – is grist for Dennis’ mill. If it’s interesting, if it affects your life, then Dennis will be talking about it – with passion, humor, insight and wisdom.

Sean Hannity is a conservative radio and television host, and one of the original primetime hosts on the Fox News Channel, where he has appeared since 1996. Sean Hannity began his radio career at a college station in California, before moving on to markets in the Southeast and New York. Today, he’s one of the most listened to on-air voices. Hannity’s radio program went into national syndication on September 10, 2001, and airs on more than 500 stations. Talkers Magazine estimates Hannity’s weekly radio audience at 13.5 million. In 1996 he was hired as one of the original hosts on Fox News Channel. As host of several popular Fox programs, Hannity has become the highest-paid news anchor on television.

Michelle Malkin is a mother, wife, blogger, conservative syndicated columnist, longtime cable TV news commentator, and best-selling author of six books. She started her newspaper journalism career at the Los Angeles Daily News in 1992, moved to the Seattle Times in 1995, and has been penning nationally syndicated newspaper columns for Creators Syndicate since 1999. She is founder of conservative Internet start-ups Hot Air and Twitchy.com. Malkin has received numerous awards for her investigative journalism, including the Council on Governmental Ethics Laws (COGEL) national award for outstanding service for the cause of governmental ethics and leadership (1998), the Reed Irvine Accuracy in Media Award for Investigative Journalism (2006), the Heritage Foundation and Franklin Center for Government & Public Integrity's Breitbart Award for Excellence in Journalism (2013), the Center for Immigration Studies' Eugene Katz Award for Excellence in the Coverage of Immigration Award (2016), and the Manhattan Film Festival's Film Heals Award (2018). Married for 26 years and the mother of two teenage children, she lives with her family in Colorado. Follow her at michellemalkin.com. (Photo reprinted with kind permission from Peter Duke Photography.)

Sponsored by:

Salem News Channel

RSS Feed

Deputy AG Todd Blanche Defends Partial Release of the Epstein Files

Deputy AG Todd Blanche defends partial release of the Epstein Files, stating that eventually the DOJ will meet the obligaion to release all of the files.

Read More...

VP J.D. Vance Reflects on First Year of the Trump Admin, Major Progress Made

As the 1-year mark dawns for the 2nd Donald Trump administration, Vice President J.D. Vance says he's proud of what they have accomplished over a short amount of time.

Read More...

Harvest with Greg Laurie, December 28, 2025

Harvest with Greg Laurie, December 28, 2025

Read More...

Real Life with Jack Hibbs, December 28, 2025

Real Life with Jack Hibbs, December 28, 2025

Read More...

On the ground at Turning Point USA

On the Ground at Turning Point USA

Read More...

Trump seizes second Venezuelan oil tanker

Trump Seizes Second Venezuelan Oil Tanker

Read More...

Fulton County's 2020 Election Fraud

Fulton County's 2020 Election Fraud

Read More...

Interview With U.S. Senator Dave McCormick

Interview With U.S. Senator Dave McCormick

Read More...

The Real Explanation Significance Of The Epstein Files

The Real Explanation Significance Of The Epstein Files

Read More...

The Fraud of Fulton County; Second Oil Tanker Seized

The Fraud of Fulton County; Second Oil Tanker Seized

Read More...

More Gun Control in Australia...

Australia Prime Minister says: Firearms will be collected and destroyed.

Read More...

Brown University Shooter Found Dead

Brown University Shooter Found Dead

Read More...

Is Tucker Carlson a lunatic?

Is Tucker Carlson a Lunatic? 

Read More...

Strange Development of Brown University Shooting

Strange Development of Brown University Shooting

Read More...

Trump Admin's Interior Success in 2025

Trump Admin's Interior Success in 2025

Read More...

Justice Department releases more Epstein records

The U.S. Justice Department released a new trove of documents from its investigations into the late financier and convicted sex offender Jeffrey Epstein on Friday, bowing to pressure from lawmakers who forced their disclosure with a new law. The release follows months of political wrangling and rebellion by some of President Donald Trump's staunchest supporters over his administration's reluctance to make public all records tied to probes into Epstein. Reuters is in the process of reviewing the latest documents. Trump had initially urged fellow Republicans in Congress to oppose the new law, warning that releasing potentially sensitive internal investigative records could set a dangerous precedent. But many Trump voters accused his administration of covering up Epstein’s ties to powerful figures and obscuring details surrounding his death, which was ruled a suicide, in a Manhattan jail in 2019. Trump, who promised on the 2024 election campaign trail to declassify the government's Epstein files if elected, has been seeking to move beyond the affair so that he can concentrate on a more pressing concern for Americans - the cost of living - ahead of the November 2026 midterm elections. Just 44% of American adults who identify as Republicans approve of Trump's handling of the Epstein issue, compared to his 82% overall approval rating among the group, according to a recent Reuters/Ipsos poll. Epstein's ties to Trump have been in the spotlight since Democrats in the House of Representatives last month released thousands of emails including one in which Epstein wrote that Trump "knew about the girls" without clarifying what that meant. House Republicans released more emails the same day, including one saying Trump visited Epstein's house many times but "never got a massage." Two days after those disclosures, Trump ordered the Justice Department to investigate Epstein's connections to former Democratic President Bill Clinton and JPMorgan bank (JPM.N). The following week, despite White House pressure to delay the vote, U.S. lawmakers voted overwhelmingly to pass a bill forcing the release of the Justice Department records, which Trump then signed into law. Trump has repeatedly denied knowing about Epstein's sex trafficking but has acknowledged that the two were friends until they had a falling out before Epstein's conviction in 2008. The latest files released may not represent all unclassified records held by the agency, however, because the law ordering their release allowed the Justice Department to withhold personal information about Epstein's victims as well as material that would jeopardize an active investigation. Previous disclosures of Epstein records have revealed that even after his 2008 conviction he continued corresponding with high-profile figures, including former Trump adviser Steve Bannon, Clinton's former U.S. Treasury Secretary Larry Summers, PayPal founder Peter Thiel, and Britain's former Prince Andrew, now known as Andrew Mountbatten-Windsor, who was stripped of his royal title over revelations about his links to Epstein. Spokespeople and lawyers for Bannon, Thiel and Mountbatten-Windsor have not responded to Reuters requests for comment about their interactions with Epstein. Summers stepped back from positions at Harvard University, OpenAI and other institutions and said he was deeply ashamed of his actions after documents released by House Democrats in November showed that Summers corresponded with Epstein up through 2019, even seeking relationship advice from him. JPMorgan paid some of Epstein's victims $290 million in 2023 to settle claims that it had overlooked his sex trafficking. The bank kept Epstein on as a client for five years after he was convicted of soliciting a minor in 2008.

Read More...

Trump Strikes Deals With Pharmaceutical Companies To Cut Prices

President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government's Medicaid program and for cash payers, in his latest bid to align U.S. costs with those in other wealthy nations. Bristol Myers Squibb, Gilead Sciences, and Merck and Roche's U.S. unit Genentech have struck deals. Novartis, Amgen, Boehringer Ingelheim, Sanofi and GSK have also signed on. "We were subsidizing the entire world. We're not doing it anymore," Trump said at a White House press conference, flanked by nine drugmaker executives. Mehmet Oz, the director of the Centers for Medicare and Medicaid Service, said Regeneron, Johnson & Johnson, and AbbVie would visit the White House after the holidays for the launch of the government's TrumpRx website. Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior administration officials said, promising "massive savings" on widely used medicines without giving specific figures. U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere. The details of each deal were not immediately available but officials said they included agreements to cut cash-pay direct-to-consumer prices of select drugs sold potentially through the TrumpRx.gov website, to launch drugs in the U.S. at prices equal to - not lower than - those in other wealthy nations and to increase manufacturing. In return, companies can receive a three-year exemption from any tariffs. MERCK'S JANUVIA, JANUMET ON TRUMPRX Merck said it will sell its diabetes drugs Januvia, Janumet and Janumet XR - set to face generic competition next year - directly to U.S. consumers at about 70% off list prices. If approved, its experimental cholesterol drug enlicitide will also be offered through direct-to-consumer channels. Enlicitide is one of two Merck drugs expected to receive a speedy review under the FDA's new, fast-track pathway, Reuters previously reported. Amgen said it will expand its direct-to-patient program to include migraine drug Aimovig and rheumatoid arthritis medicine Amjevita, offering both at $299 a month - nearly 60% and 80% below current U.S. list prices In July, Trump sent letters to leaders of 17 major drugmakers, urging them to offer so-called most-favored-nation prices to Medicaid and ensure new medicines launch at prices no higher than those in other wealthy countries. Five companies had previously struck deals with the administration to rein in prices - Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk and EMD Serono, the U.S. division of Germany's Merck KGaA. The remaining three that have not announced deals are Regeneron, Johnson & Johnson, and AbbVie. Investors initially feared sweeping U.S. price controls, but the details of recent deals have largely eased those concerns. Reuters previously reported that AbbVie was expected to announce a deal on Friday. Drugmakers on Friday committed to “most-favored-nation” pricing on all new U.S. drug launches across commercial, government and cash-pay markets, including the U.S. Medicare program for those aged 65 and over, officials said. A portion of revenues from each company's foreign sales will also be remitted to the U.S. to offset costs, officials said. The companies pledged together to invest more than $150 billion in U.S. for R&D and manufacturing, according to officials, although it was unclear whether that included earlier commitments. Several also agreed to donate drug ingredients to the U.S. strategic reserve. Merck said it chipped in $70 billion of that sum. Analysts have noted that Medicaid, which accounts for only around 10% of U.S. drug spending, already benefits from substantial price discounts, exceeding 80% in some cases. Pfizer, which announced its 2026 financial outlook on Tuesday, said the Medicaid discounts would result in price and margin compression next year.

Read More...

First ... 62 63 64 65 66 ... Last

Salem News Channel Today

Sponsored Links

On Air & Up Next

See the Full Program Guide